NVAX logo Novavax : NVAX

NVAX

Stock Data

$8.04

Change up

$0.12 (1.45%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Novavax Inc is a biotechnology firm focused on enhancing global health by creating vaccines for serious infectious diseases. It uses innovative technologies like recombinant protein, nanoparticle technology, and its unique Matrix-M adjuvant to boost immune responses. The company has developed a COVID-19 vaccine, marketed under various names, for adults and adolescents. Additionally, Novavax is working on vaccines for influenza and a combination of influenza and COVID-19, as well as a malaria vaccine. Founded in 1987, Novavax is based in Gaithersburg, Maryland.

All Novavax Articles

202 Articles

1 2 3 14

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.